Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy von Viñal, D., Gutierrez-Sainz, L., Martinez, D., Garcia-Cuesta, J. A., Pedregosa, J., Villamayor, J., Ostios, L., Sanchez-Cabrero, D., Higuera, O., Pinto, A., Rodriguez-Salas, N., Espinosa, E., de Castro, J., Feliu, J.

Volltext

Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review von Solares, I., Viñal, D., Morales-Conejo, M., Rodriguez-Salas, N., Feliu, J.

Volltext

Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies von Viñal, D., Minaya-Bravo, A., Prieto, I., Feliu, J., Rodriguez-Salas, N.

Volltext

Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review von Viñal, D., Rodriguez-Salas, N., Perez-Wert, P., Higuera, O., Ghanem, I., Feliu, J.

Volltext

Clinical and pathological features in colorectal cancer associated to Lynch syndrome von Higuera, O., Rodriguez, A., Rodriguez-Salas, N., Ruiz-Giménez, L., Gallego, A., Ghanem, I., Custodio, A., Sanchez, D., Ostios, L., Poma, J. Miranda, Feliu, J.

Volltext

Retrospective analysis of clinical factors associated with a greater benefit with Trifluridine and Tipiracil in metastasic colorectal cancer von Rodriguez-Salas, N., Segura, M. Soriano, Jimenez-Gordo, A., Molina, R., Cámara, J., Alfonso, A. Lopez, Martínez-Amores, B., Fernandez, A. Pertejo, Reynoso, G., Poma, J. Miranda

Volltext

Raltitrexed as salvage therapy for metastatic colorectal cancer: A multicenter retrospective study von Ghanem, I., Viudez, A., García-Torralba, E., Torres-Tenor, J., Carmona, A., Vera, R., Rodriguez-Salas, N., de la Peña, F. Ayala, Higuera, O., Feliu, J.

Volltext

Clinical guideline SEOM: hepatocellular carcinoma von Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J.

Volltext

Diagnosis and Treatment of Merkel Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline of the Spanish Academy of Dermatology and Venereology von Vázquez Doval, J, Llombart Cussac, B, Pérez Bustillo, A, Paradela de la Morena, S, Fuente González, M J, Fernández Figueras, M T, Villanueva, M J, Rodríguez Salas, N, Descalzo-Gallego, M Á, García-Doval, I, Ríos-Buceta, L

Volltext

Clinical guideline SEOM: hepatocellular carcinoma von Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J.

Volltext

ΔNp73 and Δ133p53 in liquid biopsy as early diagnostic markers for colorectal cancer von Rodriguez-Cobos, J., Viñal, D., Poves, C., Fernández-Aceñero, M., Santos-Lopez, J., Carnicero, P., Amor, A., Peinado, H., Barderas, R., Rodríguez-Salas, N., Domínguez, G.

Volltext

Descriptive analysis of clinical factors affecting terminally ill cancer patients von Jiménez-Gordo, A. M., Feliu, J., Martínez, B., de-Castro, J., Rodríguez-Salas, N., Sastre, N., Vilches, Y., Espinosa, E., Rodríguez-Aizcorbe, J. R., González-Barón, M.

Volltext

Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-... von Aparicio, J., Virgili, A., Capdevila, J., Muñoz Boza, F., Álvarez, R., Bosch, C., Cámara, J., Fernandez-Martos, C., Fernandez-Plana, J., Gallego, J., Gallego, R., Hernández-Yagüe, X., Macías Declara, I., Rodríguez-Salas, N., Vera, R., Taberner, M., Maurel, J.

Volltext

9P Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study von Salazar Soler, R., Santos Vivas, C., Macias, I., Yubero Esteban, A., Bassam, A., Gallego Plazas, J., Al-Farhat, Y., Cervantes, A., García Alfonso, P., Paez, D., Ruiz-Casado, A., Lopez, C., Árkosy, P.F., Furka, A., Rodriguez-Salas, N., Ramos Pascual, F.J., Cubillo Gracian, A., Hitre, E., Ferreiro Monteagudo, R., Salud Salvia, M.A.

Volltext

Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients von de Toro Carmena, M., Ortega Morán, L., García Adrián, S., Castañón López, C., Molina Villaverde, R., Marrupe González, D., Lopez Muñoz, A., Alcaraz Nunes, D., Díaz Beveridge, R., López Alfonso, A., García Paredes, B., Fernández Montes, A., Soriano Rodríguez, M., Encinas García, S., Alcaide García, J., Pericay Pijaume, C., Macarulla Mercadé, T., Rodríguez-Salas, N., García Alfonso, P., Muñoz Martín, A.

Volltext

1069P A multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021) von Rubio, X. Mielgo, Diaz-Beveritge, R., Sanchez, J.M. Sepulveda, Pineda, E., Salgado, M.Á. Vaz, Lecumberri, M.J., Valverde, C., Castro, R. Lopez, López, C., Echaburu, J.A. Virizuela, Salas, N. Rodriguez, Bataller, R. de las Penas, Lopez, R. Lopez, Rodriguez, J. Medina, Rodriguez-Antona, C., Berraondo, P., Rodriguez-Moreno, J.F., Nuño, A. Hurtado, Sevillano, E., Garcia-Donas, J.

Volltext

382P Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) trea... von Valladares, M., Safont Aguileria, M.J., González-Flores, E., García Alfonso, P., López Muñoz, A.M., Aranda Aguilar, E., Falco Ferrer, E., Rodriguez-Salas, N., Cirera, L., Llanos-Munoz, M., Aparicio, J., Pimentel, P., Castillo Trujillo, A.O., Salgado Fernandez, M., Salud Salvia, M.A., Vidal Tocino, R., Massuti Sureda, B., Garcia-Carbonero, R., Vicente Conesa, M.A.D.L.A., Lloansi Vila, A.

Volltext

P-236Clinical and pathological features in colorectal cancer associated to Lynch syndrome von Higuera, O, Rodriguez, A, Rodriguez-Salas, N, Ruiz-Giménez, L, Gallego, A, Ghanem, I, Custodio, A, Sanchez, D, Ostios, L, Poma, J Miranda, Feliu, J

Volltext

455P Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colo... von Valladares-Ayerbes, M., Safont, M.J., González-Flores, E., García-Alfonso, P., Aranda Aguilar, E., López Muñoz, A.M., Cirera Nogueras, L., Falco Ferrer, E., Rodriguez Salas, N., Aparicio, J., Llanos, M., Castillo Trujillo, O.A., Pimentel Cáceres, P., Cruz-Hernández, J.J., Salgado Fernández, M., Salud Salvia, A., Garcia-Carbonero, R., Massuti Sureda, B., Vicente Conesa, M.A., Lloansi Vila, A.

Volltext

P-266Retrospective analysis of clinical factors associated with a greater benefit with Trifluridine and Tipiracil in metastasic colorectal cancer von Rodriguez-Salas, N, Segura, M Soriano, Jimenez-Gordo, A, Molina, R, Cámara, J, Alfonso, A Lopez, Martínez-Amores, B, Fernandez, A Pertejo, Reynoso, G, Poma, J Miranda

Volltext